M. Dorta

发表

Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer.

D. Planchard, L. Lacroix, B. Besse, 2022, Clinical lung cancer.

Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial.

D. Planchard, N. Chaput, J. Mazières, 2021, Lung cancer.